Comparison Of Two Different Type Robot Assisted Gait Training In Rehabilitation Of Stroke

Comparison Of An Exoskeleton Device With An End-Effector Device In Robotic Gait Assesment Of Stroke

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03565185

Enrollment

Registered

2018-06-21

Start date

2018-06-30

Completion date

2020-04-01

Last updated

2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Investigators aimed to compare the results of rehabilitation with an exoskeleton device(Robogait) and with an end-effector device(Lokohelp)

Detailed description

There are different types of devices in robotic rehabilitation which has been used in recent years for stroke. Investigators aimed to compare the results of rehabilitation with an exoskeleton device(Robogait) and with an end-effector device(Lokohelp) in robot-assisted gait training of stroke rehabilitation

Interventions

OTHERrobot-assisted gait training

Investigators will use robot-assisted gait training for rehabilitation of stroke

OTHERplacebo

Investigators will use only conventional treatment without robot-assisted gait training

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Rehabilitation need for stroke * Patients under FAC stage 4 * No contraindications for robotic rehabilitation * Subacute stroke

Exclusion criteria

* The robot-orthosis does not fit the patient's body * Inadequate body weight (obesity) * Severe contractures * Bone instability (nonstable spinal cord fracture and severe osteoporosis) * Circulation problems * Cardiac problems * Open wounds on the lower extremities or in the body where they will come into contact with the orthosis * Uncoordinated, psychotic or aggressive patients * Serious cognitive disorders * Patients with long-term infusion therapy * Hip, knee, ankle arthrodesis * Epilepsy * Patients with disproportionate limb or vertebrae, such as bone cartilage dysplasia * Those with severe vascular problems of the lower extremity * Conditions requiring rest or immobilization, such as osteomyelitis and other inflammatory/infectious diseases * Severe respiratory diseases

Design outcomes

Primary

Measure	Time frame	Description
6 minute walk test	4 weeks	6 minute walk test for walking speed
10 meter walking test	4 weeks	10 meter walking test for walking
Postural Assessment Scale for Stroke(PASS)	4 weeks	Postural Assessment Scale for Stroke(PASS) will be used

Secondary

Measure	Time frame	Description
FAC(Functional Ambulation Classification)	4 weeks	FAC will be used for ambulation
Barthel Index	4 weeks	Barthel Index will be used for daily living activities

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026